6-145805057-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PP3_ModerateBS2
The NM_032145.5(FBXO30):āc.1349A>Gā(p.Asp450Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000558 in 1,613,908 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_032145.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FBXO30 | NM_032145.5 | c.1349A>G | p.Asp450Gly | missense_variant | 2/3 | ENST00000237281.5 | NP_115521.3 | |
FBXO30 | NM_001348092.2 | c.1349A>G | p.Asp450Gly | missense_variant | 2/3 | NP_001335021.1 | ||
FBXO30 | XM_047419398.1 | c.1457A>G | p.Asp486Gly | missense_variant | 2/3 | XP_047275354.1 | ||
EPM2A-DT | NR_038246.1 | n.53-23304T>C | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FBXO30 | ENST00000237281.5 | c.1349A>G | p.Asp450Gly | missense_variant | 2/3 | 1 | NM_032145.5 | ENSP00000237281.3 | ||
EPM2A-DT | ENST00000629681.1 | n.91-4721T>C | intron_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152182Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000438 AC: 11AN: 251216Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135766
GnomAD4 exome AF: 0.0000575 AC: 84AN: 1461726Hom.: 0 Cov.: 60 AF XY: 0.0000509 AC XY: 37AN XY: 727166
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152182Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74358
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 26, 2024 | The c.1349A>G (p.D450G) alteration is located in exon 2 (coding exon 1) of the FBXO30 gene. This alteration results from a A to G substitution at nucleotide position 1349, causing the aspartic acid (D) at amino acid position 450 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at